Flexion Can Double Now That FDA Has Approved Zilretta

Flexion jumped 10% as it's first drug, Zilretta, was approved by the FDA. As the opioid epidemic worsens, doctors are looking for non-addictive drugs like Zilretta for patients in pain. Todd Hagopian thinks the stock can double from here.